RBC Bioscience Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 173.89 million compared to TWD 251.18 million a year ago. Net income was TWD 3.78 million compared to TWD 28.73 million a year ago.

Basic earnings per share from continuing operations was TWD 0.29 compared to TWD 2.43 a year ago. Diluted earnings per share from continuing operations was TWD 0.29 compared to TWD 2.34 a year ago.